Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life

Lymphoma survivors after high-dose therapy with autologous stem-cell transplant (HDT-ASCT) are at risk of several late effects, which might impair their health-related quality of life (HRQoL). We assessed the total late effect burden in this population, and how it affects HRQoL. All lymphoma survivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Smeland, Knut, Holte, Harald, Fagerli, Unn-Merete, Bersvendsen, Hanne, Hjermstad, Marianne J., Loge, Jon H., Murbræch, Klaus, Linnsund, Marianne D., Fluge, Øystein, Stenehjem, Jo S., Lund, May B., Kvaløy, Stein, Kiserud, Cecilie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Quality of Life
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614512/
https://www.ncbi.nlm.nih.gov/pubmed/35484681
http://dx.doi.org/10.3324/haematol.2021.280413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614512/
https://www.ncbi.nlm.nih.gov/pubmed/35484681
http://dx.doi.org/10.3324/haematol.2021.280413

Ejemplares similares